Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about N-ACETYLCYSTEINE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | N-ACETYLCYSTEINE |
| Key Genes/Proteins | CDK5, CHRNA7, ERK, GPX4, GSH, HMOX1 |
| Related Diseases | FERROPTOSIS, GLAUCOMA, GLIOSIS, HYPERTENSION |
graph TD
N_ACETYLCYSTEINE["N-ACETYLCYSTEINE"]
N_ACETYLCYSTEINE -->|"inhibits"| Ferroptosis["Ferroptosis"]
N_ACETYLCYSTEINE -->|"inhibits"| ROS["ROS"]
N_ACETYLCYSTEINE -->|"treats"| Herpes_Simplex_Keratitis["Herpes Simplex Keratitis"]
N_ACETYLCYSTEINE -->|"inhibits"| Disulfidptosis["Disulfidptosis"]
N_ACETYLCYSTEINE -->|"targets"| Oxidative_Stress["Oxidative Stress"]
N_ACETYLCYSTEINE -->|"activates"| TNF["TNF"]
JNK["JNK"] -->|"activates"| N_ACETYLCYSTEINE
APOPTOSIS["APOPTOSIS"] -->|"activates"| N_ACETYLCYSTEINE
MICRORNA_REGULATION["MICRORNA REGULATION"] -->|"target for"| N_ACETYLCYSTEINE
ERK["ERK"] -->|"activates"| N_ACETYLCYSTEINE
HYPERTENSION["HYPERTENSION"] -->|"activates"| N_ACETYLCYSTEINE
MAPK["MAPK"] -->|"activates"| N_ACETYLCYSTEINE
GLIOSIS["GLIOSIS"] -->|"activates"| N_ACETYLCYSTEINE
AXON["AXON"] -->|"activates"| N_ACETYLCYSTEINE| Target | Relation | Type | Str |
|---|---|---|---|
| Oxidative Stress | inhibits | process | 0.90 |
| Ferroptosis | inhibits | process | 0.85 |
| paracetamol | interacts_with | entity | 0.85 |
| Herpes Simplex Keratitis | treats | disease | 0.82 |
| Disulfidptosis | inhibits | process | 0.80 |
| Paracetamol Hepatoprotection | promotes | process | 0.80 |
| Oxidative Stress | targets | process | 0.75 |
| NEURODEGENERATION | protects_against | phenotype | 0.70 |
| FERROPTOSIS | targets | phenotype | 0.65 |
| CDK5 | inhibits | gene | 0.65 |
| CDK5 | activates | gene | 0.65 |
| CDK5 | treats | gene | 0.65 |
| TFEB | associated_with | gene | 0.50 |
| NRF2 | associated_with | gene | 0.50 |
| HO-1 | associated_with | gene | 0.50 |
| RIPK1 | associated_with | gene | 0.50 |
| KEAP1 | associated_with | gene | 0.50 |
| HMOX1 | associated_with | gene | 0.50 |
| LAMP1 | associated_with | gene | 0.50 |
| MTOR | associated_with | gene | 0.50 |
| ROS | therapeutic_target | protein | 0.50 |
| GPX4 | associated_with | gene | 0.50 |
| ROS | activates | protein | 0.50 |
| OXIDATIVE STRESS | associated_with | phenotype | 0.50 |
| SORAFENIB | associated_with | drug | 0.45 |
| TNF | associated_with | gene | 0.45 |
| TAU | associated_with | protein | 0.45 |
| GLIOSIS | associated_with | phenotype | 0.45 |
| NAC | associated_with | drug | 0.45 |
| P38 | associated_with | gene | 0.45 |
| MAPK | associated_with | gene | 0.45 |
| PYROPTOSIS | associated_with | phenotype | 0.45 |
| DEFERIPRONE | associated_with | drug | 0.45 |
| JNK | associated_with | gene | 0.45 |
| APOPTOSIS | associated_with | phenotype | 0.45 |
| ROS | associated_with | phenotype | 0.45 |
| SULFORAPHANE | associated_with | drug | 0.45 |
| RAPAMYCIN | associated_with | drug | 0.45 |
| INFLAMMATION | associated_with | phenotype | 0.45 |
| NECROPTOSIS | associated_with | phenotype | 0.45 |
| DEFEROXAMINE | associated_with | drug | 0.45 |
| CDK5 | associated_with | gene | 0.45 |
| FERROPTOSIS | associated_with | phenotype | 0.45 |
| TNF | inhibits | gene | 0.35 |
| SORAFENIB | inhibits | drug | 0.35 |
| NEUROINFLAMMATION | activates | process | 0.35 |
| NEURODEGENERATION | activates | process | 0.35 |
| P38 | activates | gene | 0.35 |
| NUCLEUS ACCUMBENS | regulates | brain_region | 0.35 |
| TNF | activates | gene | 0.35 |
| Source | Relation | Type | Str |
|---|---|---|---|
| GPX4 | activates | gene | 0.70 |
| JNK | activates | gene | 0.50 |
| APOPTOSIS | activates | process | 0.50 |
| NEURODEGENERATION | associated_with | phenotype | 0.50 |
| MAPK | associated_with | gene | 0.45 |
| FERROPTOSIS | associated_with | phenotype | 0.45 |
| GLIOSIS | associated_with | phenotype | 0.45 |
| JNK | associated_with | gene | 0.45 |
| APOPTOSIS | associated_with | phenotype | 0.45 |
| DEFEROXAMINE | associated_with | drug | 0.45 |
| AUTOPHAGY | activates | process | 0.35 |
| AUTOPHAGY | associated_with | process | 0.35 |
| FERROPTOSIS | activates | process | 0.35 |
| CHRNA7 | regulates | gene | 0.35 |
| CHRNA7 | expressed_in | gene | 0.35 |
| ERK | activates | gene | 0.35 |
| HYPERTENSION | activates | disease | 0.35 |
| MAPK | activates | gene | 0.35 |
| GLIOSIS | activates | process | 0.35 |
| MICRORNA REGULATION | therapeutic_target | process | 0.35 |
| GLIOSIS | inhibits | process | 0.35 |
| GLAUCOMA | protects_against | disease | 0.35 |
| GLIOSIS | protects_against | process | 0.35 |
| GSH | activates | gene | 0.35 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| N-acetylcysteine (NAC) / System Xc⁻ - Mediated GSH Support f | 0.760 | neurodegeneration | Can ferroptosis inhibitors prevent BBB d |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning N-ACETYLCYSTEINE in their description or question text
No additional research found